// startup autopsy

CollabRx

CollabRx offered cloud-based expert systems for selecting molecular disease treatments like cancer based on patient genetic data.

timingAcqui-hire

Fatal mistake: Attempted to commercialize genomic interpretation before clinical workflows, reimbursement models, and hospital IT infrastructure were ready to support it.

Founded	2008
Closed	2012
Country	USA
Sector	Healthtech

50%

Key Events Timeline

2008-01-01

FOUNDING

CollabRx founded to build a genomic data interpretation platform targeting oncology decision support.

2011-08-01

FUNDING

Raised approximately $1.56M to accelerate product development and clinical partnerships.

2012-03-01

PRODUCT LAUNCH

Released genomic interpretation tools for oncologists but faced slow hospital adoption due to workflow integration challenges.

2012-12-01

SHUTDOWN

Acqui-hired after insufficient commercial traction, closing independent operations.

Full Analysis

Analyst plan

Documented cause

CollabRx pioneered genomic data interpretation for cancer treatment but encountered significant obstacles that prevented sustainable operations. The startup raised under $1.6M, which proved insufficient to fund...

both R&D and commercial expansion. The company faced slow clinical adoption of its genomic analysis platform, a common challenge in precision medicine where healthcare providers require extensive val

Verified lesson

“...”

Unlock full lesson →

€2.8M

Peak valuation

HypeCycle · MoatType · ResearchTags

CollabRx raised €1.564572M before attempted to commercialize genomic interpretation before clinical workflows, reimbursement models, and hospital it infrastructure were ready to support it. ended it. See the documented cause, verified lesson and all failure signals.

Unlock full analysis →Create free account

See all plans·Analyst plan — €149/mo